Chargement en cours...

Insights into RNA binding by the anticancer drug cisplatin from the crystal structure of cisplatin-modified ribosome

Cisplatin is a widely prescribed anticancer drug, which triggers cell death by covalent binding to a broad range of biological molecules. Among cisplatin targets, cellular RNAs remain the most poorly characterized molecules. Although cisplatin was shown to inactivate essential RNAs, including riboso...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Nucleic Acids Res
Auteurs principaux: Melnikov, Sergey V., Söll, Dieter, Steitz, Thomas A., Polikanov, Yury S.
Format: Artigo
Langue:Inglês
Publié: Oxford University Press 2016
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4889946/
https://ncbi.nlm.nih.gov/pubmed/27079977
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/nar/gkw246
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!